Estradiol analogs attenuate autophagy, cell migration and invasion by direct and selective inhibition of TRPML1, independent of estrogen receptors. Rühl, P., Rosato, A. S., Urban, N., Gerndt, S., Tang, R., Abrahamian, C., Leser, C., Sheng, J., Jha, A., Vollmer, G., Schaefer, M., Bracher, F., & Grimm, C. Scientific Reports, 11(1):8313, April, 2021.
Paper doi abstract bibtex Abstract The cation channel TRPML1 is an important regulator of lysosomal function and autophagy. Loss of TRPML1 is associated with neurodegeneration and lysosomal storage disease, while temporary inhibition of this ion channel has been proposed to be beneficial in cancer therapy. Currently available TRPML1 channel inhibitors are not TRPML isoform selective and block at least two of the three human isoforms. We have now identified the first highly potent and isoform-selective TRPML1 antagonist, the steroid 17β-estradiol methyl ether (EDME). Two analogs of EDME, PRU-10 and PRU-12, characterized by their reduced activity at the estrogen receptor, have been identified through systematic chemical modification of the lead structure. EDME and its analogs, besides being promising new small molecule tool compounds for the investigation of TRPML1, selectively affect key features of TRPML1 function: autophagy induction and transcription factor EB (TFEB) translocation. In addition, they act as inhibitors of triple-negative breast cancer cell migration and invasion.
@article{ruhl_estradiol_2021,
title = {Estradiol analogs attenuate autophagy, cell migration and invasion by direct and selective inhibition of {TRPML1}, independent of estrogen receptors},
volume = {11},
issn = {2045-2322},
url = {https://www.nature.com/articles/s41598-021-87817-4},
doi = {10.1038/s41598-021-87817-4},
abstract = {Abstract
The cation channel TRPML1 is an important regulator of lysosomal function and autophagy. Loss of TRPML1 is associated with neurodegeneration and lysosomal storage disease, while temporary inhibition of this ion channel has been proposed to be beneficial in cancer therapy. Currently available TRPML1 channel inhibitors are not TRPML isoform selective and block at least two of the three human isoforms. We have now identified the first highly potent and isoform-selective TRPML1 antagonist, the steroid 17β-estradiol methyl ether (EDME). Two analogs of EDME, PRU-10 and PRU-12, characterized by their reduced activity at the estrogen receptor, have been identified through systematic chemical modification of the lead structure. EDME and its analogs, besides being promising new small molecule tool compounds for the investigation of TRPML1, selectively affect key features of TRPML1 function: autophagy induction and transcription factor EB (TFEB) translocation. In addition, they act as inhibitors of triple-negative breast cancer cell migration and invasion.},
language = {en},
number = {1},
urldate = {2023-09-17},
journal = {Scientific Reports},
author = {Rühl, Philipp and Rosato, Anna Scotto and Urban, Nicole and Gerndt, Susanne and Tang, Rachel and Abrahamian, Carla and Leser, Charlotte and Sheng, Jiansong and Jha, Archana and Vollmer, Günter and Schaefer, Michael and Bracher, Franz and Grimm, Christian},
month = apr,
year = {2021},
pages = {8313},
}
Downloads: 0
{"_id":"k9AFega7xzujKbCeA","bibbaseid":"rhl-rosato-urban-gerndt-tang-abrahamian-leser-sheng-etal-estradiolanalogsattenuateautophagycellmigrationandinvasionbydirectandselectiveinhibitionoftrpml1independentofestrogenreceptors-2021","author_short":["Rühl, P.","Rosato, A. S.","Urban, N.","Gerndt, S.","Tang, R.","Abrahamian, C.","Leser, C.","Sheng, J.","Jha, A.","Vollmer, G.","Schaefer, M.","Bracher, F.","Grimm, C."],"bibdata":{"bibtype":"article","type":"article","title":"Estradiol analogs attenuate autophagy, cell migration and invasion by direct and selective inhibition of TRPML1, independent of estrogen receptors","volume":"11","issn":"2045-2322","url":"https://www.nature.com/articles/s41598-021-87817-4","doi":"10.1038/s41598-021-87817-4","abstract":"Abstract The cation channel TRPML1 is an important regulator of lysosomal function and autophagy. Loss of TRPML1 is associated with neurodegeneration and lysosomal storage disease, while temporary inhibition of this ion channel has been proposed to be beneficial in cancer therapy. Currently available TRPML1 channel inhibitors are not TRPML isoform selective and block at least two of the three human isoforms. We have now identified the first highly potent and isoform-selective TRPML1 antagonist, the steroid 17β-estradiol methyl ether (EDME). Two analogs of EDME, PRU-10 and PRU-12, characterized by their reduced activity at the estrogen receptor, have been identified through systematic chemical modification of the lead structure. EDME and its analogs, besides being promising new small molecule tool compounds for the investigation of TRPML1, selectively affect key features of TRPML1 function: autophagy induction and transcription factor EB (TFEB) translocation. In addition, they act as inhibitors of triple-negative breast cancer cell migration and invasion.","language":"en","number":"1","urldate":"2023-09-17","journal":"Scientific Reports","author":[{"propositions":[],"lastnames":["Rühl"],"firstnames":["Philipp"],"suffixes":[]},{"propositions":[],"lastnames":["Rosato"],"firstnames":["Anna","Scotto"],"suffixes":[]},{"propositions":[],"lastnames":["Urban"],"firstnames":["Nicole"],"suffixes":[]},{"propositions":[],"lastnames":["Gerndt"],"firstnames":["Susanne"],"suffixes":[]},{"propositions":[],"lastnames":["Tang"],"firstnames":["Rachel"],"suffixes":[]},{"propositions":[],"lastnames":["Abrahamian"],"firstnames":["Carla"],"suffixes":[]},{"propositions":[],"lastnames":["Leser"],"firstnames":["Charlotte"],"suffixes":[]},{"propositions":[],"lastnames":["Sheng"],"firstnames":["Jiansong"],"suffixes":[]},{"propositions":[],"lastnames":["Jha"],"firstnames":["Archana"],"suffixes":[]},{"propositions":[],"lastnames":["Vollmer"],"firstnames":["Günter"],"suffixes":[]},{"propositions":[],"lastnames":["Schaefer"],"firstnames":["Michael"],"suffixes":[]},{"propositions":[],"lastnames":["Bracher"],"firstnames":["Franz"],"suffixes":[]},{"propositions":[],"lastnames":["Grimm"],"firstnames":["Christian"],"suffixes":[]}],"month":"April","year":"2021","pages":"8313","bibtex":"@article{ruhl_estradiol_2021,\n\ttitle = {Estradiol analogs attenuate autophagy, cell migration and invasion by direct and selective inhibition of {TRPML1}, independent of estrogen receptors},\n\tvolume = {11},\n\tissn = {2045-2322},\n\turl = {https://www.nature.com/articles/s41598-021-87817-4},\n\tdoi = {10.1038/s41598-021-87817-4},\n\tabstract = {Abstract\n The cation channel TRPML1 is an important regulator of lysosomal function and autophagy. Loss of TRPML1 is associated with neurodegeneration and lysosomal storage disease, while temporary inhibition of this ion channel has been proposed to be beneficial in cancer therapy. Currently available TRPML1 channel inhibitors are not TRPML isoform selective and block at least two of the three human isoforms. We have now identified the first highly potent and isoform-selective TRPML1 antagonist, the steroid 17β-estradiol methyl ether (EDME). Two analogs of EDME, PRU-10 and PRU-12, characterized by their reduced activity at the estrogen receptor, have been identified through systematic chemical modification of the lead structure. EDME and its analogs, besides being promising new small molecule tool compounds for the investigation of TRPML1, selectively affect key features of TRPML1 function: autophagy induction and transcription factor EB (TFEB) translocation. In addition, they act as inhibitors of triple-negative breast cancer cell migration and invasion.},\n\tlanguage = {en},\n\tnumber = {1},\n\turldate = {2023-09-17},\n\tjournal = {Scientific Reports},\n\tauthor = {Rühl, Philipp and Rosato, Anna Scotto and Urban, Nicole and Gerndt, Susanne and Tang, Rachel and Abrahamian, Carla and Leser, Charlotte and Sheng, Jiansong and Jha, Archana and Vollmer, Günter and Schaefer, Michael and Bracher, Franz and Grimm, Christian},\n\tmonth = apr,\n\tyear = {2021},\n\tpages = {8313},\n}\n\n\n\n\n\n\n\n","author_short":["Rühl, P.","Rosato, A. S.","Urban, N.","Gerndt, S.","Tang, R.","Abrahamian, C.","Leser, C.","Sheng, J.","Jha, A.","Vollmer, G.","Schaefer, M.","Bracher, F.","Grimm, C."],"key":"ruhl_estradiol_2021","id":"ruhl_estradiol_2021","bibbaseid":"rhl-rosato-urban-gerndt-tang-abrahamian-leser-sheng-etal-estradiolanalogsattenuateautophagycellmigrationandinvasionbydirectandselectiveinhibitionoftrpml1independentofestrogenreceptors-2021","role":"author","urls":{"Paper":"https://www.nature.com/articles/s41598-021-87817-4"},"metadata":{"authorlinks":{}},"html":""},"bibtype":"article","biburl":"https://bibbase.org/zotero/MicaelCunha","dataSources":["c5omsHuXiMyvDCiav"],"keywords":[],"search_terms":["estradiol","analogs","attenuate","autophagy","cell","migration","invasion","direct","selective","inhibition","trpml1","independent","estrogen","receptors","rühl","rosato","urban","gerndt","tang","abrahamian","leser","sheng","jha","vollmer","schaefer","bracher","grimm"],"title":"Estradiol analogs attenuate autophagy, cell migration and invasion by direct and selective inhibition of TRPML1, independent of estrogen receptors","year":2021}